Introduction: Pleural biopsy for pathological confirmation is the standard diagnostic procedure for pleural diseases, transthoracic ultrasonography (TUS) has evolved as an important imaging tool for diagnosing pleural and pulmonary conditions.
Introduction
Pleural biopsy for histologic confirmation is the standard diagnostic procedure for pleural diseases. The pleural involvement by tuberculosis or by a malignancy is not uniform. The result of a blind closed biopsy without any guidance may not be diagnostic [1] . Transthoracic ultrasonography (TUS) has evolved as an important imaging technique for diagnosing pleural and pulmonary conditions [2] . Ultrasonography may detect abnormal areas of the pleura that may be targeted for biopsy. Yield is improved with this approach when compared with random pleural sampling. [3] . Thoracoscopy remains the most efficient and the gold standard; however cost-effective approach to the diagnosis of pleural exudates, it allows for the direct inspection of the pleura and biopsies taken under direct vision, and has a diagnostic yield of 91-95% for malignant disease and as high as 100% for pleural tuberculosis [4] .
Aim of the study
To assess the diagnostic yield of TUS guided pleural biopsy versus both CT guided and thoracoscopic pleural biopsy in the diagnosis of exudative pleural effusion.
Patients and methods

Study design
Observational prospective clinical comparative study.
The study was conducted at chest department, Zagazig University Hospitals in the period from January 2013 to June 2015. The study included 60 patients with undiagnosed exudative pleural effusion.
Tools and instruments used for data collection included: 
Patient enrollment in the study
Patients with exudative pleural effusion who fail to be diagnosed by the previously mentioned conventional methods, after signing an informed consent were assigned according to the method by which pleural biopsy was obtained into three groups (A, B, C). They were assigned randomly (by systematic random methods, the first patient underwent US guided pleural biopsy; next patient CT guided pleural biopsy, and the third patient thoracoscopic pleural biopsy and so on). Patients who failed to reach final diagnosis by TUS or CT guided biopsy were referred to medical thoracoscopy group and managed accordingly. Group A: 20 Patients with exudative pleural effusion for whom Chest US guided pleural biopsy was done (Samsung, Medison Sono, Ace R3, ultrasound system, Korea) using 18-gauge needle of 20 cm length (TSK UROCUT biopsy needle).
Group B: 20 Patients with exudative pleural effusion for whom CT guided pleural biopsy was done. Scan was done using multi-slice CT scanner (General Electric, Milwaukee, USA). After identification of the maximum area of pleural thickening, under aseptic technique and local anesthesia, an 18-gauge needle of 20 cm length (TSK UROCUT biopsy needle. Japan) was inserted tangentially and closed until the area of maximum thickness of the parietal pleura is reached, then opened to gain an adequate core of pleural tissue.
Group C: 27 Patients with exudative pleural effusion for whom medical thoracoscopic guided pleural biopsy was done (karl Storz LTD, Germany), 20 patients plus 4 patients who failed to be diagnosed by US guided biopsy and 3 patients who failed to be diagnosed by CT guided biopsy. Inspection of the pleural cavity, biopsy and electrocoagulation of any resultant serious bleeding was done. Pre-thoracoscopic chest US was done for the detection of any encystment or pleural thickening before procedure.
End point of the study
To reach final diagnosis by any of the previous method patients, i.e. who were undiagnosed by US guided pleural biopsy (Group A) or CT guided pleural biopsy (Group B), were referred to thoracoscopy group (Group C) to get the chance for final diagnosis.
Results
The study included 60 patients with exudative pleural effusion; 27 females and 33 males, 38 patients who were current smoker, 6 patients ex-smoker and 16 patients were non-smoker. The mean age was 52 ± 10.3 years; there were 38 patients with no co-morbidities however 22 patients had co-morbidities in the form of 4 hypertensive patients, 11 diabetic patients, 3 patients with past history of cancer and 4 hepatic patients. Twenty-seven patients were with RT sided pleural effusion, 28 patients with left sided pleural effusion and 5 patients with bilateral pleural effusion Table 1 . There was no statistically significant difference between groups regarding pleural fluid parameters (P 0.38) except WBC count which was higher in the CT guided biopsy group (p 0.03).
Final etiological diagnosis
The etiological diagnosis of the studied patients: 48 patients (80%) were of malignant etiology: [17 patients with Iry pleural malignancy (28.3%), 9 patients with hematological malignancy: (15%), 22 patients with metastatic carcinoma (36.6%)] while 10 patients (16.6%) showed inflammatory pathology [2 patients with TB (3.3%), 8 patients with CTD (13.3%)] and 2 patients remained undiagnosed even after thoracoscopic. Table 2 .
Diagnostic yield of the three studied modalities TUS was diagnostic in 80% of patients, CT guided pleural biopsy was diagnostic in 85% of cases, while thoracoscopic pleural biopsy was diagnostic in 92.5% of cases without statistical significance (p 0.45) Table 3 . 
Complications
Complications of medical thoracoscopy were intra-operative bleeding |(one patient), broncho-pleural fistula (2 patients), failure of lung expansion (4 patients, 3 of those patients had longer duration of the procedure), surgical emphysema (5 patients, 4 of those patients had longer duration of the procedure), and one patient developed post-operative empyema, 14 patients developed no complications Table 4 .
Complications of image guided pleural biopsy
Procedure related Pain was reported in 18 patients (90%) in TUS guided pleural biopsy group Vs 20 patients (100%) in CT guided pleural biopsy group, 1 patient (5%) developed pneumothorax in TUS Vs 3 patients (15%) in CT, 7 patients (35%) developed hemoptysis in TUS Vs 10 patients (50%) in CT, 4 patients (20%) suffered from bleeding from biopsy site in TUS Vs 12 patients (60%) in CT and 3 patients (15%) suffered from post-procedural shock in TUS Vs 2 patients (10%) in CT with no statistically significant difference between both procedures. Table 5 .
Discussion
Undiagnosed pleural effusions represent an increasing diagnostic burden upon healthcare providers internationally. The investigation of pleural effusions often requires the acquisition of tissue for histological analysis and diagnosis. Historically there were two options for tissue biopsy: a 'gold standard' surgical biopsy or a ''blind" closed pleural biopsy. Over the last decade however, image-guided Tru-cut biopsies and local tho-racoscopic biopsies have become more widespread Dixon et al. [5] . Image-guided techniques acquire samples under ultrasound (US) or computed tomography (CT) guidance whereas MT involves the direct visualization and biopsy of the pleura. The introduction of US into the thoracic medicine and its availability as a bedside, cheap and its association with minimal complications motivated the present study to assess its diagnostic yield and complications versus both CT guided and thoracoscopic pleural biopsy.
This study was carried out on Sixty patients with exudative pleural effusion in whom routine and specific pleural fluid analysis were not diagnostic, their mean age was 52 ± 10.3 years. Malignancy was the most common etiology among the studied patients in the three groups 48/60 (80%) whether primary pleural or metastatic; this was consistent with the findings of Mohamed et al. [10] , Selim et al. [8] , Prabhu and Narasimhan [7] and Sudheer et al. [6] where they studied patients with undiagnosed pleural effusion and most of their patients were within the mean age group. While in the study of Nithya and Suraj [14] , the mean age was slightly lower than that found in the present study (43.04 ± 10.05 years), where the dominant etiologies in their study were tuberculosis, and pneumonia, while malignancies was the third.
In the present study, TUS guided pleural biopsy was diagnostic in 16 patients out of 20 patients with 80% diagnostic accuracy; those 16 patients were, 11 patients with pleural malignancy, 4 patients with connective tissue disorders, one patient with tuberculous effusion. CT guided pleural biopsy was diagnostic in 85% (17 patients out of 20 patients while medical thoracoscopy (MT) was diagnostic in 92.5% of cases (25 patients out of 27)) ( Table 3 ). In the present study TUS was the lowest diagnostic yield among the three studied modalities. This could be attributed to the random allocation of patients in the study groups directly affected the diagnostic yield of US group of patients since pleural thickening which is favorable to US was present only in 3 patients Vs 8 patients in the CT guided group and 5 in the MT group. TUS allowed real time visualization of the biopsy needle with no radiation risk for the patient, cheap, readily accessible, and well tolerated, no need for sedation and the procedure is carried out as a day case where discharge is possible after brief observation Giles et al. [15] . In comparison to CT guided biopsy which is usually performed by a trained and experienced radiologist and the medical thoracoscopy which is usually done under direct vision, TUS had shown the lowest but accepted diagnostic yield in the present study (80% Vs 85% for CT guided biopsy and 92.5% for MT) without a statistical significance (p = 0.45) ( Table 5) .
Glies et al. [15] , reviewed multiple studies and reported a diagnostic yield of TUS 77%, 83% for CT guided biopsy and 92.6% for medical thoracoscopy, Matthew et al. [9] reported a diagnostic yield of 81% for TUS guided pleural biopsy Vs 100% for MT, Mohamed et al. [10] reported a diagnostic yield of TUS guided pleural biopsy (75%) Vs (100%) for MT and Qureshi et al. [11] , reported a diagnostic yield of 86.5% for TUS guided pleural biopsy Vs 97% for CT guided pleural biopsy. All the previously mentioned studies reported comparable results to the finding of the present study.
On the other hand higher diagnostic yield of TUS was reported by Sconfienza et al. [13] (97% for TUS guided biopsy Vs 96.5% for CT guided biopsy) and Hallifax et al. [12] reported a diagnostic yield of 94% for TUS guided pleural biopsy Vs 100% for MT. The higher yield of US in the study of Sconfienza et al. [13] could be attributed to patient selection in the study where most selected patients had had pleural lesions (31 patients) and peripherally located pulmonary lesions (72 patients).
Regarding complications reported in the present study; in the medical thoracoscopy group; 14 patients out of 27 patients developed no complications (51.85%). However; the most commonly encountered complication was surgical emphysema in 5 patients (18.5%) followed by failure of lung expansion in 4 patients (14.8%), 2 patients developed broncho-pleural fistula (7.4%), one patient developed intra-operative bleeding (3.7%), and one patient developed empyema (3.7%) ( Table 4 ).
Most complication occurred in patients in whom the procedure was prolonged more than 30 min and a positive correlation was found in the present study between the time of the procedure and the development of complications (r = 0.36, p = 0.06).
The development of surgical emphysema is a common complication of thoracotomy and intercostals tube insertion even with minimal manipulation and its occurrence with MT may be higher due to excessive manipulations which are more traumatizing to the chest wall structures including the skin and subcutaneous tissues and intercostals muscles. Higher incidence of surgical was reported by Hosny et al., 2013 during medical thoracoscopy where surgical emphysema occurred in 14/40 patients (35%)
Regarding complications of TUS and CT guided pleural biopsy in the present study although chest pain was higher in CT than in TUS 20/20 patients (100%) VS 18/20 patients (90%), bleeding at biopsy site 12/20 patients in CT (60%) Vs 4 patients in TUS (20%), hemoptysis 10/20 patients (50%) in CT Vs 7/20 patients (35%) in TUS, pneumothorax in 3/20 patients (15%) Vs 1/20 patients in TUS (5%), and shock 2/20 patients in CT (10%) Vs 3/20 patients in TUS (15%) but without statistical significance (p = 0.6). Similar findings were reported by Glies et al. [15] who reported that TUS guided pleural biopsy developed mild hemoptysis in (19%). Sconfienza et al. [13] reported post TUS pneumothorax in 5.8%. Glies et al. [15] CT guided biopsy developed complications in the form of pneumothorax in 2% and bleeding at the site of biopsy in 7.5%. Sconfienza et al. [13] showed CT guided biopsy developed post procedural pneumothorax in 14.7% and hemothorax in 1.2%. In conclusion, Thoracic ultrasound (TUS) guided pleural biopsy is a safe procedure, with a diagnostic yield which was slightly lower but comparable to both CT guided pleural biopsy and medical thoracoscopic pleural biopsy (MT). When done prior to medical thoracoscopy, it can detect thick fibrous septations and multiloculation. Alert the thoracoscopist to the likely presence of thick fibrous adhesions which may prolong the procedure and impede lung expansion.
